FINHUB Insights

AMGN · Q2 FY26 · Apr 1 – Jun 30, 2026

Amgen Q2 FY26: where the revenue came from and where it went

Amgen Q2 FY26: revenue $10.1B (+10% year over year). Net profit $2.4B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2026
Reported
May 1, 2026 10-Q
Sankey diagram of Amgen's income statement for Q2 FY26: revenue of $10.1 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$10.1B +10% year over year
Gross profit$7.2B 72% margin
Operating profit$3.5B 35% margin
Net profit$2.4B 24% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
ItemValueShare of revenueYear over year
Revenue 10.1 100% +10%
Cost of revenue−2.828%
Gross profit7.272% margin+5pp
SG&A−1.717%−1pp
Other−2.020%+0pp
Operating profit3.535% margin+6pp
Tax−0.4
Interest & other costs−0.7
Net profit2.424%+8pp

Source of the numbers: tables in the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.